We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

58 hedge funds and large institutions have $154M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

5% more capital invested

Capital invested by funds: $146M → $154M (+$7.48M)

4% more funds holding

Funds holding: 56 → 58 (+2)

Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
8
Closed
6
Calls
$100K
Puts
–
Net Calls
+$100K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
+$6.55M
2
SCM
Saba Capital Management
New York
+$6.01M
3
UOC
UBS O'Connor
Illinois
+$4.2M
4
FTCM
First Trust Capital Management
Illinois
+$3.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.75M

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$6.55M
2
Citadel Advisors
Citadel Advisors
Florida
-$6M
3
BCM
Beryl Capital Management
California
-$5.65M
4
MI
MMCAP International
Cayman Islands
-$5M
5
SC
Sculptor Capital
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
51
Dupont Capital Management
Delaware
$251K – – –
COPPSERS
52
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$251K +$250K +25,000 New
PP
53
Paloma Partners
Connecticut
$200K – – –
Capstone Investment Advisors
54
Capstone Investment Advisors
New York
$100K – – –
USPCM
55
Union Square Park Capital Management
New York
$100K – – –
UBS Group
56
UBS Group
Switzerland
$21K +$18.9K +1,887 +899%
TRCT
57
Tower Research Capital (TRC)
New York
$7K +$4.64K +464 +167%
MF
58
Magnetar Financial
Illinois
$2.38K +$2.38M +237,600 New
Citadel Advisors
59
Citadel Advisors
Florida
– -$6M -600,000 Closed
BCM
60
Beryl Capital Management
California
– -$5.65M -565,016 Closed
SCC
61
Spring Creek Capital
Kansas
– -$2.5M -250,000 Closed
BCM
62
Basso Capital Management
Connecticut
– -$53K -5,288 Closed
AA
63
Ancora Advisors
Ohio
– -$50K -5,000 Closed
PFS
64
Prospera Financial Services
Texas
– -$1K -100 Closed
1 2
3

IQMD Hedge Fund Activity: Q2 2022 in Review

58 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q2 2022, worth a combined $154M — up 5.1% from $146M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new IQMD positions and 6 closed out — a net gain of 2 holders — while 15 added to existing stakes and 8 trimmed.

The largest buyer was HSBC Holdings, opening a new position worth an estimated $6.55M. The largest seller was Linden Advisors, cutting an estimated $6.55M.

  • 58 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q2 2022, up from 56 in Q1 2022.
  • Funds reported $154M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q2 2022, up 5.1% quarter-over-quarter.
  • 8 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q2 2022 and 6 closed out, a net change of +2 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q2 2022 was HSBC Holdings, an estimated $6.55M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q2 2022 was Linden Advisors, an estimated $6.55M sold.

Based on aggregated 13F filings for Q2 2022.